Organon OGN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.12B+94.4% | $574M-14.6% | $672M+12.2% | $599M+9.5% | $547M-19.0% | ||
| $1.38B+4.0% | $1.33B-10.3% | $1.48B0.0% | $1.48B+1.9% | $1.46B+7.3% | ||
| $252M+6.8% | $236M-4.5% | $247M+2.9% | $240M+15.9% | $207M-3.7% | ||
| $13M-7.1% | $14M0.0% | $14M+16.7% | $12M-53.8% | $26M+4.0% | ||
| $800M+1.1% | $791M-5.3% | $835M+3.2% | $809M+17.6% | $688M+1.9% | ||
| $734M-2.3% | $751M-5.9% | $798M-0.7% | $804M+3.5% | $777M+1.7% | ||
| $1.06B+2.5% | $1.03B-2.2% | $1.06B-2.3% | $1.08B+7.6% | $1.01B+1.1% | ||
| $0-100% | $8M— | —— | —— | —— | ||
| $74M-8.6% | $81M-3.6% | $84M+21.7% | $69M-14.8% | $81M+2.5% | ||
| $4.93B+13.3% | $4.35B-7.4% | $4.7B+1.8% | $4.62B+5.7% | $4.37B+0.5% | ||
| $1.28B-1.8% | $1.3B+1.0% | $1.29B+1.9% | $1.27B+5.8% | $1.2B+2.5% | ||
| $4.15B0.0% | $4.15B-11.3% | $4.68B0.0% | $4.68B0.0% | $4.68B0.0% | ||
| $1.1B-2.7% | $1.13B-15.7% | $1.34B-1.6% | $1.36B-3.9% | $1.42B+0.2% | ||
| $56M-1.8% | $57M-8.1% | $62M-10.1% | $69M0.0% | $69M-6.8% | ||
| $1.53B-0.4% | $1.54B-0.2% | $1.54B-2.0% | $1.57B+5.6% | $1.49B0.0% | ||
| $13B+1.0% | $12.87B-5.1% | $13.55B+0.4% | $13.5B+2.6% | $13.16B+0.4% | ||
| $983M+3.3% | $952M-11.4% | $1.07B+0.7% | $1.07B+6.1% | $1.01B-12.7% | ||
| $16M0.0% | $16M-64.4% | $45M-60.9% | $115M+475% | $20M0.0% | ||
| $0-100% | $2M— | —— | —— | —— | ||
| $77M-9.4% | $85M-26.7% | $116M-40.2% | $194M+10.2% | $176M+31.3% | ||
| $2.5B+4.6% | $2.39B-10.8% | $2.68B-4.2% | $2.8B+6.9% | $2.62B-3.8% | ||
| $8.55B-0.9% | $8.63B-1.8% | $8.78B0.0% | $8.78B-1.7% | $8.94B+0.9% | ||
| $984M-2.4% | $1.01B-10.2% | $1.12B+0.1% | $1.12B+12.8% | $994M+1.7% | ||
| $12.09B-0.2% | $12.12B-4.2% | $12.65B-0.9% | $12.77B+1.2% | $12.61B-0.1% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+16,567% | ||
| $186M+11.4% | $167M+5.0% | $159M+14.4% | $139M+6.9% | $130M+20.4% | ||
| $1.25B+13.0% | $1.11B-15.9% | $1.32B+13.3% | $1.16B+13.4% | $1.03B+1.6% | ||
| -$539M-2.3% | -$527M+8.2% | -$574M-0.3% | -$572M+7.3% | -$617M+4.9% | ||
| $903M+20.1% | $752M-17.0% | $906M+23.6% | $733M+35.2% | $542M+14.8% | ||
| $13B+1.0% | $12.87B-5.1% | $13.55B+0.4% | $13.5B+2.6% | $13.16B+0.4% | ||
| $216M-0.5% | $217M-19.0% | $268M-4.3% | $280M+12.4% | $249M+33.9% | ||
| $14M+16.7% | $12M0.0% | $12M0.0% | $12M0.0% | $12M-14.3% | ||
| $14M+16.7% | $12M0.0% | $12M0.0% | $12M0.0% | $12M-14.3% | ||
| $1.06B+2.5% | $1.03B-2.2% | $1.06B-2.3% | $1.08B+7.6% | $1.01B+1.1% | ||
| $135M+18.4% | $114M-10.2% | $127M-12.4% | $145M0.0% | $145M+9.0% | ||
| $1.53B-0.4% | $1.54B-0.2% | $1.54B-2.0% | $1.57B+5.6% | $1.49B0.0% | ||
| $1.1B-2.7% | $1.13B-15.7% | $1.34B-1.6% | $1.36B-3.9% | $1.42B+0.2% | ||
| $9M-10.0% | $10M+11.1% | $9M+12.5% | $8M-20.0% | $10M+42.9% | ||
| $1.42B+6.7% | $1.34B-7.5% | $1.44B+1.7% | $1.42B+0.5% | $1.41B+0.1% | ||
| $77M-9.4% | $85M-26.7% | $116M-40.2% | $194M+10.2% | $176M+31.3% | ||
| $32M+300% | $8M-42.9% | $14M-53.3% | $30M-67.0% | $91M+550% | ||
| $1M— | —— | $32M-69.2% | $104M+1,633% | $6M— | ||
| $9M— | —— | $3.57B-0.1% | $3.57B+2.3% | $3.49B— | ||
| $77M-4.9% | $81M-5.8% | $86M-4.4% | $90M-3.2% | $93M-4.1% | ||
| $8.57B-2.6% | $8.8B-0.3% | $8.83B-0.8% | $8.9B-0.7% | $8.96B-0.9% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 262.6M+0.9% | 260.3M+0.1% | 260M0.0% | 260M+0.8% | 258M+0.1% | ||
| $186M+11.4% | $167M+5.0% | $159M+14.4% | $139M+6.9% | $130M+20.4% | ||
| $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $0— | —— | $0— | $0— | $0— | ||
| 5.9M-21.8% | 7.5M-17.8% | 9.1M0.0% | 9.1M-2.9% | 9.4M+35.5% | ||
| $179M— | —— | $146M-15.1% | $172M-22.2% | $221M— | ||
| $29.23— | —— | $31.790.0% | $31.79+0.3% | $31.69— | ||
| $26.31-3.6% | $27.30+7.4% | $25.430.0% | $25.430.0% | $25.42-13.7% | ||
| $26.31— | —— | $25.430.0% | $25.430.0% | $25.42— | ||
| $14M+16.7% | $12M0.0% | $12M0.0% | $12M0.0% | $12M-14.3% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | $500M0.0% | ||
| $262.65M+0.9% | $260.32M+0.1% | $259.98M0.0% | $259.97M+0.8% | $257.95M+0.1% | ||
| $262.65M+0.9% | $260.32M+0.1% | $259.98M0.0% | $259.97M+0.8% | $257.95M+0.1% | ||
| $16M0.0% | $16M-64.4% | $45M-60.9% | $115M— | —— | ||
| $77M-4.9% | $81M-5.8% | $86M-4.4% | $90M-3.2% | $93M-4.1% | ||
| $56M-1.8% | $57M-8.1% | $62M-10.1% | $69M0.0% | $69M-6.8% | ||
| $179M— | —— | $146M-15.1% | $172M-22.2% | $221M— | ||
| $1.63B-1.0% | $1.64B-5.4% | $1.74B+2.4% | $1.69B+8.0% | $1.57B+2.1% | ||
| $13M-7.1% | $14M0.0% | $14M+16.7% | $12M-53.8% | $26M+4.0% | ||
| $0-100% | $32M— | —— | —— | —— | ||
| $9M-10.0% | $10M+11.1% | $9M+12.5% | $8M-20.0% | $10M+42.9% | ||
| $3.5B— | —— | $10M0.0% | $10M-83.9% | $62M— | ||
| $9M— | —— | $3.57B-0.1% | $3.57B+2.3% | $3.49B— | ||
| $21M— | —— | $10M0.0% | $10M+11.1% | $9M— | ||
| $61M— | —— | $10M0.0% | $10M-60.0% | $25M— | ||
| $1M— | —— | $32M-69.2% | $104M+1,633% | $6M— | ||
| $5.03B— | —— | $5.26B0.0% | $5.26B-3.3% | $5.44B— | ||
| 6— | —— | 60.0% | 60.0% | 6— | ||
| 70— | —— | 700.0% | 700.0% | 70— | ||
| —— | —— | 20.0% | 2— | —— | ||
| $32M+300% | $8M-42.9% | $14M-53.3% | $30M-67.0% | $91M+550% | ||
| $26.31— | —— | $25.430.0% | $25.430.0% | $25.42— | ||
| $5.88M-21.8% | $7.52M-17.8% | $9.15M0.0% | $9.15M-2.9% | $9.42M+35.5% | ||
| $5.77M— | —— | $8.83M+0.7% | $8.77M-2.3% | $8.98M— | ||
| $0— | —— | $0— | $0— | $0— | ||
| $26.31-3.6% | $27.3+7.4% | $25.430.0% | $25.430.0% | $25.42-13.7% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $6.61-5.4% | $6.99+8.9% | $6.420.0% | $6.42+0.5% | $6.39-17.0% | ||
| $216M-0.5% | $217M-19.0% | $268M-4.3% | $280M+12.4% | $249M+33.9% | ||
| $1M— | —— | $32M-69.2% | $104M+1,633% | $6M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Organon cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Organon's balance sheet data come from?
- Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.